Avanos Medical AVNS reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Avanos Medical beat estimated earnings by 8.57%, reporting an EPS of $0.38 versus an estimate of $0.35.
Revenue was up $18.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 2.18% drop in the share price the next day.
Here's a look at Avanos Medical's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | 0.38 | 0.26 | 0.40 | 0.30 |
EPS Actual | 0.41 | 0.26 | 0.46 | 0.25 |
Revenue Estimate | 208.27M | 197.80M | 191.32M | 185.34M |
Revenue Actual | 203.00M | 197.40M | 193.40M | 184.10M |
To track all earnings releases for Avanos Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.